![]() |
市場調查報告書
商品編碼
1847170
全球髓內釘市場:市場規模、佔有率和趨勢分析(2025-2031 年)Intramedullary Nails Market Size, Share, & Trends Analysis | Global | 2025-2031 | Includes: Humeral Intramedullary Nails, Forearm Intramedullary Nails, and 2 more |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
2024年全球髓內釘(IM)市值為12億美元。預計該市場將持續成長,到2031年將達到15億美元。
本報告涵蓋全球髓內釘市場的所有產品細分領域,包括肱骨、前臂、股骨、脛骨和踝關節髓內釘。報告量化了銷量、平均售價 (ASP)、市場規模、成長率和企業市場占有率。此外,報告還分析了市場促進因素、限制因素、手術量、近期併購以及技術趨勢。本研究提供了截至 2021 年的歷史資料以及截至 2031 年的預測資料。
市場概覽
髓內釘固定是整形外科創傷固定的基石,尤其治療方法長骨骨折的治療。與傳統的鋼板固定系統相比,髓內釘固定能夠在髓腔內實現內部穩定,從而實現更早期的活動和更佳的負荷分佈。過去十年,髓內釘固定已成為股骨和脛骨骨折的首選治療方法,其應用範圍也擴展到肱骨和踝關節。
外科技術的進步和植入設計的創新使髓內釘成為創傷治療的重要組成部分。製造商不斷改進髓內釘的形狀、鎖定機制和手術器械,以提高其插入的便利性、對位精度和動態性能。這些進步有助於縮短手術時間、減少併發症並改善臨床療效。
儘管已開發地區的髓內釘市場競爭激烈且已趨於成熟,但由於創傷治療的可及性提高,新興市場的需求正在迅速成長。全球人口老化、骨質疏鬆性骨折病例增加以及道路交通事故導致的高能量損傷增多,都推動了全球對該手術的需求。
除了創傷修復外,肢體延長和畸形矯正術也正在成為新興的成長領域。隨著企業將業務拓展到傳統骨折固定之外,專用的髓內固定系統正在被開發用於非創傷性適應症。這些應用利用髓內釘的動態特性來實現可控的骨骼延長和骨骼復位,為整形外科手術開闢了新的可能性。
整體而言,髓內釘市場正透過漸進式設計創新、更精密的器械和改進的材料不斷發展。這些趨勢預計將支撐市場在強勁的手術需求推動下保持溫和成長,但同時也受到價格壓力和其他固定方法的競爭的限制。
市場促進因素
良好的臨床結果
在長骨骨折治療中,髓內釘始終展現出優於鋼板螺絲的動態穩定性和承重能力。其負荷分擔設計允許早期活動,從而降低關節攣縮和肌肉萎縮的風險。這一特性在股骨和脛骨骨折中尤其重要,因為早期復健對長期功能恢復至關重要。
在需要持久固定的病例中,外科醫生更傾向於使用髓內釘,尤其是在軸向和扭轉穩定性至關重要的情況下。術後效果的改善,包括術後併發症的減少(感染率降低、對位更佳、住院時間更短),增強了臨床醫師對髓內釘系統的信心。這些優點持續推動著髓內釘在主要解剖部位的廣泛應用。
設備改進
雖然髓內釘本身的結構相對標準化,但競爭的差異化已轉移到器械設計。現代內固定髓內釘系統強調符合人體工學和操作簡單的器械,以簡化手術流程。
製造商正致力於研發定位裝置、擴孔工具和鎖定機構,以提高手術精度,同時最大限度地減少輻射曝射量和手術時間。簡化的定位導引裝置可降低錯位風險,而整合的深度和角度控制則可提高螺絲植入的準確性。
器械系統的持續更新是影響外科醫師偏好和品牌忠誠度的關鍵因素。隨著手術效率對購買決策的影響日益增強,提供全面、易用系統的公司將獲得競爭優勢。
踝關節髓內釘的生長
在所有解剖適應症中,踝關節髓內釘固定術是成長最快的領域。雖然鋼板螺絲固定術一直是踝關節融合和骨折修復的傳統方法,但髓內釘固定術因其能夠提供穩定的對位和較高的骨癒合率而日益受到認可。
由於其療效可靠且軟組織併發症少,髓內釘在關節融合術(用於穩定踝關節以緩解關節炎或嚴重創傷引起的疼痛)的應用日益普及。使用髓內釘進行關節融合術的正面效果,包括改善負荷分佈和減少植入外露,正在加速其推廣應用。
踝關節內釘的成長也得益於適應症的擴大、外形設計改進(例如降低釘體高度)以及外科醫師訓練的加強(尤其注重微創技術)。隨著臨床成功案例的積累,預計到2031年,踝關節內釘在所有內釘手術中所佔的佔有率將越來越大。
市場限制
競標競爭
在整形外科創傷市場,尤其是在公共醫療體系涵蓋的地區,公共採購和競標採購正變得越來越普遍。在這些體系下,政府機構或採購集團進行競爭性競標,製造商主要在價格上競爭。
這種採購模式加劇了價格競爭,對平均售價(ASP)造成了強勁的下行壓力,尤其是在中國和西歐等高需求市場。 2021年底中國推出的價值導向採購(VBP)計畫進一步加速了這一趨勢,導致多個整形外科器械類別的價格大幅下降。
雖然競標提高了准入門檻和透明度,但也使擁有大規模生產和分銷能力的成熟供應商受益,提高了規模較小或專注於特定參與企業的供應商的准入門檻。預計這種定價環境將持續下去,即使手術量持續成長,市場價值成長也會放緩。
在某些創傷病例中,外固定仍然是內固定的有效替代方案。其模組化設計允許在整個癒合過程中進行調整,從而為骨折治療提供了靈活性。外固定器在開放性骨折和複合性骨折中尤其有用,因為軟組織損傷使得即時進行內固定變得困難。
術後可調整對位以及手術的微創性,使得外固定術在特定患者群體和尋求經濟高效解決方案的醫療系統中備受青睞。因此,外固定術持續面臨激烈的市場競爭,尤其是在新興市場和資源有限的醫院。
鋼板和螺絲衝突
儘管髓內釘具有許多臨床優勢,但鋼板螺絲在整形外科固定領域仍是強大的競爭者。解剖型鋼板設計、鎖定技術和可變角度螺絲系統的進步,擴大了鋼板固定的適應症範圍。
這些創新使鋼板固定系統更加通用且創傷更小,縮小了鋼板固定和髓內釘固定在某些類型骨折中的性能差距。在某些情況下,外科醫生可能會選擇鋼板,以便更方便地取出器械或最大限度地減少髓內損傷。
儘管髓內釘在長骨治療中仍佔據主導地位,但鋼板螺絲系統的日益複雜化預計將抑制整體市場成長率。
競爭分析
2024年,DePuy Synthes在全球髓內釘市場佔據領先地位。該公司主導地位的取得歸功於其全面的Advanced Nail System和Expert Nail®產品線,這些產品涵蓋所有主要解剖適應症。髓內釘以及鋼板和螺絲是DePuy Synthes最主要的收入來源之一。持續投入產品研發和外科醫生培訓,幫助該公司保持了其全球市場佔有率,並有望在預測期內進一步鞏固其市場地位。
史賽克在全球髓內釘市場佔據第二大市場。該公司的T2™髓內釘系統仍然是創傷固定領域最受認可且臨床應用最廣泛的平台之一。 T2™產品線涵蓋多個解剖部位,並採用模組化器材以提高手術效率。史賽克專注於具有競爭力的價格以及持續拓展高成長地區,從而實現了市場佔有率的穩步成長,預計這一趨勢將持續到2031年。
2024年,史密斯醫療(Smith & Nephew)憑藉其用於股骨、肱骨和脛骨骨折的TRIGEN®髓內釘產品線,佔據了第三大市場佔有率。該公司致力於創新,專注於最佳化形狀以分散負荷並最大限度地減少軟組織刺激。儘管史密斯醫療的市場佔有率穩步成長,但來自大型跨國公司的激烈競爭限制了其快速擴張的潛力。
市場和數據覆蓋範圍
科技與臨床趨勢
地區
本版內容涵蓋全球,包括北美、歐洲、亞太地區、拉丁美洲以及中東和非洲。
74頁詳細資料和說明分析。
附錄簡稱調查方法。
圖表清單
圖表列表
調查方法
全球關稅的影響
髓內釘市場
The global intramedullary (IM) nail market was valued at $1.2 billion in 2024. The market is projected to grow, reaching $1.5 billion by 2031.
This report covers the full suite of products in the global intramedullary nail market, including humeral, forearm, femoral, tibial, and ankle IM nails. It quantifies unit sales, average selling prices (ASPs), market values, growth rates, and company shares, and analyzes market drivers, limiters, procedure numbers, recent mergers and acquisitions, and technology trends. The study provides historical data to 2021 and forecasts through 2031.
Market Overview
Intramedullary nails are a cornerstone of orthopedic trauma fixation, particularly in long-bone fracture management. Their ability to provide internal stabilization within the medullary canal allows for early mobilization and improved load sharing compared to traditional plating systems. Over the past decade, IM nails have become the preferred treatment for femoral and tibial fractures, and their use is expanding to the humerus and ankle.
Advances in surgical technique and implant design have positioned IM nails as an essential component of trauma care. Manufacturers continue to refine nail geometry, locking mechanisms, and instrumentation to improve ease of insertion, alignment accuracy, and biomechanical performance. These developments help to reduce operating times, minimize complications, and improve clinical outcomes.
While the IM nail market remains competitive and mature in developed regions, emerging markets are seeing strong volume growth as access to trauma care improves. The global aging population, rising incidence of osteoporosis-related fractures, and increased rates of high-energy injuries from road accidents are supporting procedural demand worldwide.
In addition to trauma repair, limb lengthening and deformity correction represent an emerging growth area. As companies seek to expand beyond traditional fracture fixation, specialized intramedullary systems are being developed for non-trauma indications. These applications leverage IM nail mechanics for controlled distraction osteogenesis and bone realignment, opening new opportunities in orthopedics.
Overall, the IM nail market continues to evolve through incremental design innovation, enhanced instrumentation, and improved materials. These trends are expected to sustain moderate growth in a market defined by strong procedural demand but tempered by pricing pressures and competitive overlap with alternative fixation methods.
Market Drivers
Favorable Clinical Outcomes
Intramedullary nails consistently demonstrate superior biomechanical stability and weight-bearing capacity compared with plates and screws for long-bone fractures. Their load-sharing design enables earlier mobilization, reducing the risk of joint stiffness and muscle atrophy. This characteristic is especially important in femoral and tibial fractures, where early rehabilitation can significantly improve long-term function.
Surgeons often favor IM nails in cases requiring durable fixation, particularly when both axial and torsional stability are critical. Improved postoperative outcomes-such as reduced infection rates, better alignment, and shorter hospital stays-reinforce clinical confidence in IM nail systems. These advantages continue to drive steady adoption across all major anatomical segments.
Instrumentation Improvements
Although the nail constructs themselves are relatively standardized, differentiation among competitors has shifted toward instrumentation design. Modern IM nail systems emphasize ergonomic, intuitive instrumentation that streamlines the surgical workflow.
Manufacturers are investing in targeting devices, reaming tools, and locking mechanisms that improve precision while minimizing radiation exposure and operating time. Simplified targeting guides reduce the risk of malalignment, while integrated depth and angle controls enhance accuracy in screw placement.
Continuous updates to instrumentation systems have become a key factor influencing surgeon preference and brand loyalty. As surgical efficiency increasingly shapes purchasing decisions, companies with comprehensive, user-friendly systems are gaining competitive advantage.
Growth in Ankle Nails
Among all anatomical applications, ankle IM nails represent the fastest-growing segment. Historically, plate and screw fixation dominated ankle arthrodesis and fracture repair; however, IM nails are increasingly recognized for their ability to provide stable alignment and high fusion rates.
Their use in arthrodesis procedures-which fuse the ankle joint to relieve pain from arthritis or severe trauma-has gained traction due to reliable outcomes and reduced soft-tissue complications. The favorable results associated with IM nail arthrodesis, including improved load distribution and reduced hardware prominence, are accelerating adoption.
Growth in ankle nails is further supported by expanded clinical indications, improved designs with lower profiles, and surgeon training initiatives that emphasize minimally invasive techniques. As evidence of clinical success accumulates, ankle nails are expected to account for a growing share of total IM nail procedures through 2031.
Market Limiters
Tender Competition
Public procurement and tender-based purchasing have become increasingly common in the orthopedic trauma market, particularly in regions with publicly funded healthcare systems. Under these systems, government bodies or group purchasing organizations open competitive bids in which manufacturers compete primarily on price.
This procurement model has intensified price competition and exerted strong downward pressure on ASPs, especially in high-volume markets such as China and Western Europe. The introduction of value-based procurement (VBP) programs in China at the end of 2021 further accelerated this trend, causing sharp reductions in pricing across multiple orthopedic device categories.
While tenders improve access and transparency, they also favor established suppliers with large-scale manufacturing and distribution capacity, creating high entry barriers for smaller or niche players. This pricing environment is expected to persist, moderating market value growth even as procedural volumes continue to rise.
External fixation remains a viable alternative to IM nailing in specific trauma cases. Its modular design allows adjustments throughout the healing process, providing flexibility in fracture management. External fixators are particularly useful for open or complex fractures, where soft-tissue damage precludes immediate internal fixation.
The ability to manipulate alignment postoperatively and the reduced surgical invasiveness of external fixation appeal to certain patient populations and healthcare systems seeking cost-effective solutions. As a result, external fixation continues to exert competitive pressure, particularly in emerging markets and resource-constrained hospitals.
Competition from Plates and Screws
Despite the clinical advantages of IM nails, plates and screws remain strong competitors in the orthopedic fixation landscape. Advances in anatomic plate design, locking technology, and variable-angle screw systems have expanded the range of indications treatable with plate fixation.
These innovations have made plating systems more versatile and less invasive, narrowing the performance gap between plate and IM nail fixation for certain fracture types. In some cases, surgeons may choose plates for easier hardware removal or to minimize intramedullary canal disruption.
While IM nails continue to dominate long-bone indications, the growing sophistication of plate and screw systems is expected to limit the market's overall expansion rate.
Competitive Analysis
DePuy Synthes led the global intramedullary nail market in 2024. The company's leadership stems from its comprehensive Advanced Nailing System and Expert Nail(R) product lines, which cover all major anatomical applications. IM nails represent one of DePuy Synthes' strongest revenue contributors alongside plates and screws. Continued investment in product development and surgeon education supports its dominant global share, and the company is expected to strengthen its position further during the forecast period.
Stryker ranked second in the global IM nail market. Its T2(TM) nail system remains one of the most recognized and clinically established platforms in trauma fixation. The T2(TM) line covers multiple anatomical sites and incorporates modular instrumentation designed for surgical efficiency. Stryker's focus on competitive pricing and continued expansion into high-growth regions has allowed it to steadily increase market share, a trend expected to persist through 2031.
Smith & Nephew held the third-largest share in 2024, supported by its TRIGEN(R) family of IM nails for femoral, humeral, and tibial fractures. The company's innovation has centered on optimizing geometry for load sharing and minimizing soft-tissue irritation. While Smith & Nephew achieved incremental gains in share, strong competition from larger multinational firms limits its potential for rapid expansion.
Market Coverage and Data Scope
Technology and Practice Trends
Geography
This edition provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.
74 pages of detailed data and narrative analysis.
Methodology Appendix and Acronym Glossary included.
Where are the largest and fastest-growing opportunities within the global intramedullary nail market.
How the shift toward ankle IM nails and limb lengthening applications will shape future market growth.
Which companies lead in innovation, and how their portfolios compare in scope, pricing, and clinical adoption.
How tender-based purchasing and value-based procurement programs influence global pricing dynamics.
What design and instrumentation improvements are driving surgeon preference and brand loyalty.
How IM nails compare with plates, screws, and external fixation systems in terms of cost, outcomes, and versatility.
The Global Intramedullary Nail Market Report from iData Research answers these questions with detailed market models, company share analysis, and ASP benchmarking.
It enables stakeholders to quantify demand, evaluate pricing trends, align product strategy, and identify expansion opportunities across key anatomical and regional segments.
Table Of Contents
List Of Figures
List Of Charts
Research Methodology
Impact Of Global Tariffs
Intramedullary Nail Market